Ascendiant Capital Maintains Buy on BioSig Technologies, Raises Price Target to $2.75
BioSig Technologies Analyst Ratings
バイオシグ・テクノロジーズ | 10-Q:Q3 2024 四半期報告書
BioSig Regains Compliance With Nasdaq's Minimum Bid Price Requirement
12 Health Care Stocks Moving In Monday's After-Market Session
BioSig Technologies' Common Stock To Resume Trading On The Nasdaq Exchange, Wednesday, October 23, 2024 After Its Appeal Was Granted An Extension Until March 7, 2025
バイオシグ テクノロジーズ | 10-Q:Q2 2024 四半期報告書
Biosig Technologies: Proposed Acquisition Will Require Extensive Due Diligence, Potentially Through Yr-end >BSGM
Biosig Technologies Purchase Price Will Be Paid Through the Issue of Shrs to NKC Hldrs >BSGM
BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables During Q2 2024
Sector Update: Health Care Stocks Softer Late Afternoon
Why BioSig Technologies (BSGM) Shares Are Down Over 60%
BioSig Technologies Shares Halted On Circuit Breaker To The Downside, Stock Now Down -40.2%
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press Release: BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Predictive Oncology, Augmedix, Cue Health Among Healthcare Movers
Why BioSig Technologies (BSGM) Shares Are Falling
BioSig Technologies Slumps 18% on $3M Equity Sale
Salesforce, Nutanix, Bruker Among Premarket Losers' Pack
12 Health Care Stocks Moving In Thursday's Pre-Market Session